Akanda AKAN
NASDAQ AKAN
$3.87 -0.19 (-4.68%)
As of: Aug 20, 2026 · 3:50 PM EDT

Akanda (AKAN) Receivables - Other (2022 - 2025)

Akanda (AKAN) posted quarterly Receivables - Other of $1031.0 for Q4 2025, down 99.72% year-over-year from $368172.0 in Q4 2024, and down 99.72% quarter-over-quarter from $368172.0 in Q4 2024.

Akanda (AKAN) Receivables - Other (2022 - 2025) Analysis & Trends

Akanda's Receivables - Other history runs 4 years deep, the most recent figure standing at $1031.0 for Q4 2025.

  • In Q4 2025, Receivables - Other fell 99.72% year-over-year to $1031.0; the TTM figure through Dec 2025 stood at $1031.0 (down 99.72% YoY), while the FY2025 annual figure was $1031.0, down 99.72% from the prior year.
  • Receivables - Other for Q4 2025 stood at $1031.0, down from $368172.0 in the prior quarter.
  • The five-year high for Receivables - Other was $424118.0 in Q4 2022, with the low at $1031.0 in Q4 2025.
  • The 4-year median for Receivables - Other is $149210.0 (2022), against an average of $206429.6.
  • The sharpest annual moves came in 2024 and 2025: Receivables - Other soared 310.83% in 2024, then sank 99.72% in 2025.
  • Akanda's Receivables - Other stood at $424118.0 in 2022, then plunged by 78.87% to $89617.0 in 2023, then jumped by 310.83% to $368172.0 in 2024, then tumbled by 99.72% to $1031.0 in 2025.
  • Business Quant data shows AKAN's Receivables - Other at $1031.0 in Q4 2025, $368172.0 in Q4 2024, and $89617.0 in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 43.85 Bn 42.88 Bn -
2 Teva Pharmaceutical Industries 43.02 Bn 39.37 Bn 2.15 Bn
3 Zoetis 31.47 Bn 29.79 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.59 Bn 22.79 Bn 5.10 Bn
5 United Therapeutics 22.20 Bn 19.53 Bn 683.80 Mn
6 Viatris 18.76 Bn 17.87 Bn 1.46 Bn
7 Neurocrine Biosciences 15.45 Bn 15.06 Bn 935.80 Mn
8 Elanco Animal Health 11.76 Bn 11.23 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.10 Bn 9.94 Bn -
10 Akanda 266,801.66 266,801.66 -

Historic Data

Download Data
DateValue
Dec 31, 2025 1,031.00
Dec 31, 2025 1,031.00
Dec 31, 2024 368,172.00
Dec 31, 2024 368,172.00
Dec 31, 2023 89,617.00
Dec 31, 2023 89,617.00
Dec 31, 2022 424,118.00
Dec 31, 2022 424,118.00
Jun 30, 2022 149,210.00
Jun 30, 2022 149,210.00